Development of Thermostable and Immunogenic Block Copolymer Nanoparticles (BNPs) for mRNA Delivery
- 31 March 2025
- journal article
- Published by American Chemical Society (ACS) in Biomacromolecules
- Vol. 26 (4) , 2444-2457
Abstract
Combining an amphiphilic block copolymer polybutadiene-b-poly(ethylene glycol) (PBD-b-PEO), an ionizable lipid, a helper lipid, and cholesterol produces thermostable BNPs. Luciferase mRNA-BNPs can be stored for over 1 year at 4 °C with no evidence of degradation to the mRNA or nanocarrier. In vivo, mRNA-BNPs exhibit a greater affinity for secondary lymphoid organs than mRNA-lipid nanoparticles (LNPs) and are efficiently taken up by macrophages and dendritic cells. Freshly fabricated ovalbumin (OVA) mRNA-BNPs elicit robust OVA-specific IgG and functional memory CD8+ T cells that persist for at least 5 months. Immunogenicity remains intact after 24 weeks of storage at 4 °C. Anti-PEG antibodies are not boosted by the repeated administration of mRNA-BNPs, unlike mRNA-LNPs. Syrian hamsters vaccinated with SARS-CoV-2 spike mRNA-BNPs are protected against weight loss associated with infection and potently suppress pulmonary viral loads. Protective efficacy is comparable to that conferred by a Comirnaty biosimilar. Cumulatively, mRNA-BNPs are thermostable, immunogenic and possess the potential for clinical application.Keywords
Funding Information
- Innosuisse - Schweizerische Agentur f?r Innovationsf?rderung (52910.1 IP-LS)
This publication has 64 references indexed in Scilit:
- Optimization of storage conditions for lipid nanoparticle-formulated self-replicating RNA vaccinesJournal of Controlled Release, 2022
- An imidazole modified lipid confers enhanced mRNA-LNP stability and strong immunization properties in mice and non-human primatesBiomaterials, 2022
- Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complementJournal of Controlled Release, 2022
- Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative reviewClinical Microbiology and Infection, 2021
- A subset of Kupffer cells regulates metabolism through the expression of CD36Immunity, 2021
- COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challengeImmunity, 2021
- mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stabilityInternational Journal of Pharmaceutics, 2021
- PEGylation as a strategy for improving nanoparticle-based drug and gene deliveryAdvanced Drug Delivery Reviews, 2016
- Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routesJournal of Controlled Release, 2015
- CD81 protein is expressed at high levels in normal germinal center B cells and in subtypes of human lymphomasHuman Pathology, 2010